| Dr Nancy Elaine Awender, MD | |
|
75 Arch St, Ste. 204, Akron, OH 44304-1429 | |
| (330) 375-7657 | |
| (330) 375-7693 |
| Full Name | Dr Nancy Elaine Awender |
|---|---|
| Gender | Female |
| Speciality | Ophthalmology |
| Experience | 21 Years |
| Location | 75 Arch St, Akron, Ohio |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972799740 | NPI | - | NPPES |
| 2817625 | Medicaid | OH | |
| 4234531 | Other | OH | MEDICARE ID |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207W00000X | Ophthalmology | 090452 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Medina Hospital | Medina, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Summa Physicians Inc | 2961303532 | 640 |
News Archive
CivaTech Oncology, an RTP medical device company dedicated to developing novel radiation therapy devices, announced the award of a $1M Phase II Contract from the National Institutes of Health and the National Cancer Institute to further develop and commercialize CivaSheet, a bioabsorbable uni-directional device for treatment of non-small-cell lung cancer.
On Nov. 21, 2016, the American Society of Gene & Cell Therapy released Therapeutic Gene Editing: an ASGCT White Paper, intended to provide policy-makers, patient advocates, and the interested public with the necessary background information in anticipation of an upcoming consensus report on human gene editing from the National Academy of Sciences and National Academy of Medicine (NAS), expected to be released in early 2017.
NormOxys, Inc., a biotechnology company developing a novel class of small molecule drugs which enhance the body's ability to deliver oxygen to diseased tissues, today announced that it has raised $17.5 million in a Series B financing round. The financing was led by a new investor, Care Capital, LLC, with participation from existing venture investor Index Ventures.
The 7th ChinaBio® Investor Forum, held December 2-3, 2009 in Tianjin, concluded a successful meeting by giving "Most Promising Company" awards to two young China life science companies.
› Verified 7 days ago
| Entity Name | Summa Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235167719 PECOS PAC ID: 2961303532 Enrollment ID: O20040116000295 |
News Archive
CivaTech Oncology, an RTP medical device company dedicated to developing novel radiation therapy devices, announced the award of a $1M Phase II Contract from the National Institutes of Health and the National Cancer Institute to further develop and commercialize CivaSheet, a bioabsorbable uni-directional device for treatment of non-small-cell lung cancer.
On Nov. 21, 2016, the American Society of Gene & Cell Therapy released Therapeutic Gene Editing: an ASGCT White Paper, intended to provide policy-makers, patient advocates, and the interested public with the necessary background information in anticipation of an upcoming consensus report on human gene editing from the National Academy of Sciences and National Academy of Medicine (NAS), expected to be released in early 2017.
NormOxys, Inc., a biotechnology company developing a novel class of small molecule drugs which enhance the body's ability to deliver oxygen to diseased tissues, today announced that it has raised $17.5 million in a Series B financing round. The financing was led by a new investor, Care Capital, LLC, with participation from existing venture investor Index Ventures.
The 7th ChinaBio® Investor Forum, held December 2-3, 2009 in Tianjin, concluded a successful meeting by giving "Most Promising Company" awards to two young China life science companies.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nancy Elaine Awender, MD 75 Arch St, Ste. 204, Akron, OH 44304-1429 Ph: (330) 375-7657 | Dr Nancy Elaine Awender, MD 75 Arch St, Ste. 204, Akron, OH 44304-1429 Ph: (330) 375-7657 |
News Archive
CivaTech Oncology, an RTP medical device company dedicated to developing novel radiation therapy devices, announced the award of a $1M Phase II Contract from the National Institutes of Health and the National Cancer Institute to further develop and commercialize CivaSheet, a bioabsorbable uni-directional device for treatment of non-small-cell lung cancer.
On Nov. 21, 2016, the American Society of Gene & Cell Therapy released Therapeutic Gene Editing: an ASGCT White Paper, intended to provide policy-makers, patient advocates, and the interested public with the necessary background information in anticipation of an upcoming consensus report on human gene editing from the National Academy of Sciences and National Academy of Medicine (NAS), expected to be released in early 2017.
NormOxys, Inc., a biotechnology company developing a novel class of small molecule drugs which enhance the body's ability to deliver oxygen to diseased tissues, today announced that it has raised $17.5 million in a Series B financing round. The financing was led by a new investor, Care Capital, LLC, with participation from existing venture investor Index Ventures.
The 7th ChinaBio® Investor Forum, held December 2-3, 2009 in Tianjin, concluded a successful meeting by giving "Most Promising Company" awards to two young China life science companies.
› Verified 7 days ago
Dr. Richard R Ellison, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1 Park West Blvd, Ste 150, Akron, OH 44320 Phone: 330-864-8060 Fax: 330-864-8074 | |
Dr. Nancy N Hanna, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-5290 Fax: 330-543-5292 | |
Dr. Cetin Akpolat, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 215 W Bowery St Fl 2, Akron, OH 44308 Phone: 330-543-5290 | |
Dr. David G Burket, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1 Park West Blvd, Suite 150, Akron, OH 44320 Phone: 330-864-8060 Fax: 330-864-8074 | |
Dr. William R Yeakley, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1 Park West Blvd, Suite 150, Akron, OH 44320 Phone: 330-864-8060 Fax: 330-864-8074 | |
Mary P File, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 444 N Main St, Akron, OH 44310 Phone: 330-253-1140 Fax: 330-315-6408 | |
Dr. Ian Pacey Boydstun, D.O. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-5290 Fax: 330-543-5292 |